Hutchinson Institute for Cancer Outcomes Research
The Hutchinson Institute for Cancer Outcomes Research (HICOR) is an innovative research institute leveraging the scientific excellence and oncology expertise of Fred Hutchinson Cancer Research Center. HICOR harnesses healthcare economics to reduce the cost and improve the effectiveness of cancer prevention, treatment and therapy.
HICOR is led by Scott Ramsey M.D., Ph.D and Dr. Gary H. Lyman, both members in the Cancer Prevention Program in the Public Health Sciences Division. Dr. Ramsey is a Professor in the School of Medicine, School of Pharmacy, and Institute for Public Health Genetics at University of Washington. Dr. Lyman is a practicing medical oncologist and Affiliate Professor in the Department of Health Services in the School of Public Health and the School of Pharmacy at the University of Washington.
Together they lead a multidisciplinary team devoted improving outcomes for patients. “The institute will serve as a new model for partnerships with all stakeholders in the cancer research and care delivery enterprise,” Ramsey said. “Success in this effort will result in broader use of evidence-based care, more efficient and effective models of health care delivery, and reducing the overall burden of cancer in our region.”
Our Vision - Bridging Research and Practice
The Hutchinson Institute for Cancer Outcomes Research's mission is bold: bridge research and practice to improve patients' outcomes. Leveraging the innovation and expertise of Fred Hutchinson Cancer Research Center, HICOR is building partnerships, integrating information, studying the cost and effectiveness of cancer treatments, and sharing that knowledge to improve cancer care.
HICOR, the Seattle Cancer Care Alliance and a coalition of provider groups, health insurers, and businesses are jointly launching a statewide Value in Cancer Care Initiative.
Read more »
Creating a sustainable cancer care infrastructure will require new thinking by all stakeholders including health insurers delivery systems, providers and patients. A new campaign - ASCO Choosing Wisely Initiative - is aimed at reducing the use of frequently ordered and costly interventions that lack evidence supporting their use or value in clinical cancer care.
Learn More »
HICOR will develop a robust regional oncology databank linking clinical, cost, and outcomes information--data that currently exists in silos and is largely inaccessible to those who would benefit from it most--to support implementation and rapid evaluation of system-wide interventions to improve cancer care.
Learn More »
Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect
and treat cancer and other life-threatening diseases.